Keyphrases
Policy Challenges
100%
Prescription Drugs
100%
Medicines Policy
100%
Neglected Diseases
100%
Patent Challenge
100%
Patent Policy
100%
Market Challenges
100%
Patent Markets
100%
Prescription Drug Costs
40%
Canada
20%
United States
20%
High-cost Drugs
20%
India
20%
European Countries
20%
Politicians
20%
Cumulative Effects
20%
Clinical Benefit
20%
Token
20%
Mexico
20%
Health Needs
20%
Socioeconomic
20%
Market-based
20%
Last Resort
20%
Pharmaceutical Industry
20%
Critical Mass
20%
Non-market
20%
Public Health Policy
20%
National Health Insurance
20%
Burden of Disease
20%
Maximize Profit
20%
Rich Countries
20%
Low-resource Countries
20%
Collision Course
20%
Pharmaceutical Companies
20%
Objective Health
20%
Economic Externalities
20%
Drug Costs
20%
Pharmaceutical Manufacturing
20%
Current Trajectory
20%
Production Paradigm
20%
Societal Health
20%
Production Trajectory
20%
Access Issues
20%
Drug Production
20%
Profit-maximizing
20%
Innovative Medicines
20%
Pharmaceutical R&D
20%
Legal Economy
20%
Patented Drugs
20%
Cross-border Purchase
20%
Combustible Mixture
20%
Pricing Regime
20%
Global Pharmaceuticals
20%
Public Health Needs
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neglected Disease
100%
Public Health Policy
14%
Economics, Econometrics and Finance
Economic Externality
20%
Pharmaceutical Industry
20%
Social Sciences
Pharmaceutical Industry
5%
Economic Externality
5%